Chemistry:Funobactam

From HandWiki

Funobactam is an investigational new drug that is being evaluated for the treatment of hospital-acquired bacterial pneumonia.[1] It is a β-lactamase inhibitor.[2]

References

  1. ↑ Clinical trial number NCT05204563 for "Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2) (REITAB-2)" at ClinicalTrials.gov
  2. ↑ "Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations". International Journal of Molecular Sciences 25 (13): 6814. June 2024. doi:10.3390/ijms25136814. PMID 38999924. 




Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Funobactam&oldid=4027188"